TGT
48
-2
MET
51
4
EA
46
-6
HCP
66
-2
URI
59
6
LMT
45
-4
SEE
36
2
PG
53
-2
CHK
27
7
GE
82
-2
PPL
67
-2
MPC
41
5
MRO
50
3
DAL
64
6
PX
55
2
T
60
-3
RCL
72
-2
EXPD
54
7
ORCL
73
-4
MO
33
-2
TGT
48
-2
MET
51
4
EA
46
-6
HCP
66
-2
URI
59
6
LMT
45
-4
SEE
36
2
PG
53
-2
CHK
27
7
GE
82
-2
PPL
67
-2
MPC
41
5
MRO
50
3
DAL
64
6
PX
55
2
T
60
-3
RCL
72
-2
EXPD
54
7
ORCL
73
-4
MO
33
-2
Financhill
Back

Kymera Therapeutics Stock Predictions

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
60

KYMR
Kymera Therapeutics

Last Price:
46.42
Seasonality Move:
25.63%

7 Day Trial

ALL ACCESS PASS

$ 7

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $47.30. The Score for KYMR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
60
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • The current trend is moderately bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
50.19
52-Week Low:
9.60

Prediction Charts

Market Cap:
2.92B
Price in USD:
47.30
Volume:
327.62K
Beta:
2.20

Technical Analysis

SMA50:
44.55
SMA100:
39.17
SMA200:
36.24
52-Wk Change:
148.29%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 47.30 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 48.86 48.52 49.96 47.88
Aug-29 48.76 48.25 49.89 48.10
Aug-30 48.50 48.36 49.22 47.41
Sep-3 47.70 46.27 48.84 46.26
Sep-4 45.92 46.17 47.10 45.39
Sep-5 46.29 46.60 46.69 45.34
Sep-6 47.04 45.40 48.53 43.90
Sep-9 46.06 46.19 47.02 45.66
Sep-10 46.56 46.88 46.93 44.95
Sep-11 46.49 44.77 46.90 44.65
Sep-12 44.70 44.72 46.03 44.20
Sep-13 45.07 46.08 46.47 44.53
Sep-16 46.42 48.48 49.15 46.00
Sep-17 48.73 47.30 49.20 47.25

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.